M&A Deal Summary

Novacyt Acquires Yourgene Health

On September 8, 2023, Novacyt acquired life science company Yourgene Health

Acquisition Highlights
  • This is Novacyt’s 2nd transaction in the Life Science sector.
  • This is Novacyt’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2023-09-08
Target Yourgene Health
Sector Life Science
Buyer(s) Novacyt
Deal Type Add-on Acquisition

Target

Yourgene Health

Manchester, United Kingdom
Yourgene Health is a molecular diagnostics company that offers non-invasive prenatal screening for fetal chromosome abnormalities such as Down’s Syndrome. Yourgene Health was founded in 2000 and is based in Manchester, United Kingdom.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Novacyt

Vélizy-Villacoublay, United Kingdom

Category Company
Founded 2006
Sector Life Science
Employees234
Revenue 20M GBP (2024)
DESCRIPTION

Novacyt is a provider in the field of cellular diagnostics products and services for cancer and infectious disease products and services. Novacyt was founded in 2006 and is based in Vélizy-Villacoublay, France.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: United Kingdom M&A 2 of 2
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-18 Primer Design

Hampshire, United Kingdom

Primer Design Ltd. is a molecular diagnostics company, specialises in the design, manufacture and marketing of real-time PCR kits, reagents and instrumentation, including the proprietary innovative diagnostic platform, genesig®.

Buy $18M